Fan Jincheng, chairman of Jiangsu Qian Jing Medical Technology Development Group

"Rehabilitation is one of the noblest undertakings under the sun. I have remembered this saying since the beginning of my business and used it to encourage myself and my partners to move forward. Being an enterprise has challenges, pressures and difficulties, but I would say that these are nothing in the face of real motivation. Qian Jing is determined to be a worthy leader of The rehabilitation industry in China and make a modest contribution to the great development of China's rehabilitation cause, which is the honor and unswerving pursuit of all of us. We will always fight for it!"

Fan Yancheng, President of Jiangsu Qian Jing Medical Technology Development Group

"I have been dealing with a large number of industry experts and scholars as well as first-line users, which makes me deeply feel that If Qian Jing wants to play a good role in China's rehabilitation industry as always, she needs to" change her heart "first and then" innovate ". First of all, we should have a big pattern and vision. The development of the rehabilitation industry in China lags behind the international level, but it is not good to copy foreign existing experience, which requires us to have both professional progress, but also have enough practice and experience accumulation, and make a scientific combination of the two, overall planning strategy. The second is to have the courage to take the next level, a comprehensive modern management means, and constantly improve their core competitiveness. But I believe That Qian Jing's career will surely join the great development of China's rehabilitation cause. There is a long way to go, and the prospect is waiting!"

Bi Shanming, vice President of Jiangsu Qian Jing Medical Technology Development Group

"The company has gone through 18 years, along the way, a lot of feelings. There are more customers, there are more employees, there are more suppliers, there are more investors. Correspondingly, the fierce competition in the market is not the same day. This puts new demands on our product development, quality assurance, service level and internal management. We will make every effort to make our products more humanized and high-tech, effectively control costs and benefit users with cost-effective products and services. To do these things well is to do our part well. The purpose is to finally let our society, users, employees and shareholders benefit from our capital platform."